PharmaEssentia Corporation

TWSE:6446 주식 보고서

시가총액: NT$189.7b

PharmaEssentia 관리

관리 기준 확인 3/4

PharmaEssentia CEO는 Ko-Chung Lin, Jan2017 에 임명되었습니다 의 임기는 7.83 년입니다. 는 NT$ 3.28B 가치에 해당하는 회사 주식의 1.73% 직접 소유합니다. 3.28B. 경영진과 이사회의 평균 재임 기간은 각각 5.1 년과 3.3 년입니다.

주요 정보

Ko-Chung Lin

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기7.8yrs
CEO 소유권1.7%
경영진 평균 재임 기간5.1yrs
이사회 평균 재임 기간3.3yrs

최근 관리 업데이트

Recent updates

We Think That There Are Issues Underlying PharmaEssentia's (TWSE:6446) Earnings

Aug 20
We Think That There Are Issues Underlying PharmaEssentia's (TWSE:6446) Earnings

PharmaEssentia Corporation's (TWSE:6446) 37% Price Boost Is Out Of Tune With Revenues

Jul 02
PharmaEssentia Corporation's (TWSE:6446) 37% Price Boost Is Out Of Tune With Revenues

PharmaEssentia Corporation's (TWSE:6446) 37% Price Boost Is Out Of Tune With Revenues

Jul 02
PharmaEssentia Corporation's (TWSE:6446) 37% Price Boost Is Out Of Tune With Revenues

Is There An Opportunity With PharmaEssentia Corporation's (TWSE:6446) 25% Undervaluation?

Apr 02
Is There An Opportunity With PharmaEssentia Corporation's (TWSE:6446) 25% Undervaluation?

Downgrade: Here's How Analysts See PharmaEssentia Corporation (GTSM:6446) Performing In The Near Term

Mar 18
Downgrade: Here's How Analysts See PharmaEssentia Corporation (GTSM:6446) Performing In The Near Term

PharmaEssentia Corporation (GTSM:6446) Just Reported And Analysts Have Been Cutting Their Estimates

Mar 06
PharmaEssentia Corporation (GTSM:6446) Just Reported And Analysts Have Been Cutting Their Estimates

Things Look Grim For PharmaEssentia Corporation (GTSM:6446) After Today's Downgrade

Mar 04
Things Look Grim For PharmaEssentia Corporation (GTSM:6446) After Today's Downgrade

PharmaEssentia (GTSM:6446) Is Using Debt Safely

Feb 10
PharmaEssentia (GTSM:6446) Is Using Debt Safely

CEO 보상 분석

Ko-Chung Lin 의 보수는 PharmaEssentia 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

NT$2b

Jun 30 2024n/an/a

NT$1b

Mar 31 2024n/an/a

NT$442m

Dec 31 2023n/an/a

-NT$624m

Sep 30 2023n/an/a

-NT$890m

Jun 30 2023n/an/a

-NT$1b

Mar 31 2023n/an/a

-NT$2b

Dec 31 2022n/an/a

-NT$1b

Sep 30 2022n/an/a

-NT$2b

Jun 30 2022n/an/a

-NT$2b

Mar 31 2022n/an/a

-NT$3b

Dec 31 2021NT$9mNT$9m

-NT$3b

Sep 30 2021n/an/a

-NT$3b

Jun 30 2021n/an/a

-NT$3b

Mar 31 2021n/an/a

-NT$2b

Dec 31 2020NT$9mNT$9m

-NT$2b

Sep 30 2020n/an/a

-NT$1b

Jun 30 2020n/an/a

-NT$862m

Mar 31 2020n/an/a

-NT$856m

Dec 31 2019NT$9mNT$8m

-NT$843m

보상 대 시장: TW 시장에서 비슷한 규모의 회사에 비해 Ko-Chung 의 총 보상이 합리적인지 여부를 입증하기에는 데이터가 부족합니다.

보상과 수익: Ko-Chung 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Ko-Chung Lin

7.8yrs

테뉴어

NT$9,389,000

보상

Mr. Ko-Chung Lin, Ph D., is the Founder and Chief Strategy Officer of PharmaEssentia Corporation and has been its Chief Executive Officer since January 01, 2017. He also serves as a Director at PharmaEssen...

리더십 팀

이름위치테뉴어보상소유권
Ching-Leou Teng
Chairman & Chief Pharmaceutical Officer12.2yrsNT$8.49m1.09%
NT$ 2.1b
Ko-Chung Lin
Founder7.8yrsNT$9.39m1.73%
NT$ 3.3b
Chan-Kou Hwang
Presidentno dataNT$8.49m0.61%
NT$ 1.1b
Snow Chang
Accounting Manager & Senior Manager of Finance9.1yrs데이터 없음데이터 없음
Samuel Lin
VP and Head of Business Operations & Strategy2.8yrs데이터 없음데이터 없음
Lih-Ling Lin
Chief Scientific Officer2.3yrs데이터 없음0.010%
NT$ 19.4m
Rachel Lipsitz
VP and Head of Corporate Communications & Advocacy2.8yrs데이터 없음데이터 없음
Roddy Mcilwain
Senior VP and Head of Sales & Marketing3.8yrs데이터 없음데이터 없음
Anjana Pursnani
Senior VP & Head of People2.8yrs데이터 없음데이터 없음
Albert Qin
Chief Medical Officer7.8yrs데이터 없음0.0061%
NT$ 11.6m
Narihisa Miyachi
Head of Japan Medical Affairs6.3yrs데이터 없음데이터 없음
Yen-Tung Luan
Chief Operating Officer of Taichung Plant6.3yrs데이터 없음데이터 없음

5.1yrs

평균 재임 기간

경험이 풍부한 관리: 6446 의 관리팀은 노련하고 경험 (평균 재직 기간 5.1 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Ching-Leou Teng
Chairman & Chief Pharmaceutical Officer12.2yrsNT$8.49m1.09%
NT$ 2.1b
Ko-Chung Lin
Founder3.3yrsNT$9.39m1.73%
NT$ 3.3b
Chan-Kou Hwang
President9.5yrsNT$8.49m0.61%
NT$ 1.1b
Jeffrey R. Williams
Independent Directorless than a year데이터 없음데이터 없음
Ching-Tsun Liu
Independent Directorless than a year데이터 없음0.13%
NT$ 240.3m
Jinn-Der Chang
Independent Director10.7yrsNT$120.00k0.029%
NT$ 54.5m
Jien-Heh Tien
Independent Director6.4yrsNT$120.00k0.00060%
NT$ 1.1m
Ming-Chuan Hsieh
Independent Directorless than a year데이터 없음0.0012%
NT$ 2.3m
Norio Komatsu
Chairperson of Japan3.5yrs데이터 없음데이터 없음
Shen Yi Li
Director3.3yrsNT$95.00k0.24%
NT$ 463.2m
HsuehFang Hsu
Directorless than a year데이터 없음데이터 없음
ChenJung Hsiao
Directorless than a year데이터 없음데이터 없음

3.3yrs

평균 재임 기간

경험이 풍부한 이사회: 6446 의 이사회는 경험(평균 재직 기간 3.3 년)으로 간주됩니다.